Names | |
---|---|
IUPAC name
(RS)-6-amino-2-methylheptan-2-ol
|
|
Identifiers | |
3D model (Jmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.006.144 |
MeSH | Heptaminol |
PubChem CID
|
|
UNII | |
|
|
|
|
Properties | |
C8H19NO | |
Molar mass | 145.243 g/mol |
Density | 0.895 g/mL |
Boiling point | 250 °C (482 °F; 523 K) |
Pharmacology | |
C01DX08 (WHO) | |
Oral, intravenous, intramuscular | |
Pharmacokinetics: | |
Renal | |
Hazards | |
Main hazards | Corrosive |
R-phrases | R34 |
S-phrases | S26 |
Flash point | 105 °C (221 °F; 378 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
what is ?) | (|
Infobox references | |
Heptaminol is an amino alcohol which is classified as a vasoconstrictor (C01DX08 (WHO)). It is sometimes used in the treatment of low blood pressure, particularly orthostatic hypotension. It is a potent positive inotrope (improving cardiac contraction) It is classified as a doping substance. In 2008, the cyclist Dmitriy Fofonov was tested positive at the Tour de France. In June 2010, the swimmer Frédérick Bousquet was tested positive for the substance, allegedly for buying a medicine from the pharmacy. In 2013, the cyclist Sylvain Georges was tested positive at the Giro d'Italia. In 2014, baseball player Joel Piniero tested positive as well as St. Louis Cardinals minor league baseball player Yeison Medina.